Caracterización y estandarización de modelos in vitro para el estudio de los mecanismos moleculares las miocardiopatías. (ModinviMio)

Datos básicos

Código:
PI24/00202
Protocolo:
PI24/00202
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
52.500,00 €
Año de incio:
2025
Año de finalización:
2027
PI BIOMÉDICA NACIONAL Finan. Competitiva Pública

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

INSTITUTO DE SALUD CARLOS III

Resultados del Ensayo Clínico


Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial

Esteban-Fernandez, Alberto; (...); VERISEC Registry Researchers

Article. 10.3389/fcvm.2024.1504427. 2025


Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain.

de Frutos, Fernando; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2024.12.012. 2025


Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine.

Casas, Guillem; (...); Rodriguez-Palomares, Jose F

Article. 10.1016/j.rec.2025.01.011. 2025


New ECG biomarkers and sex-stratified models for the detection of Arrhythmogenic Cardiomyopathy with left ventricular involvement

Jimenez-Serrano, Santiago; (...); Castells, Francisco

Article. 10.1016/j.bspc.2024.107224. 2025


Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.

Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C

Article. 10.1111/ctr.70027. 2025


Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.

Ufnal, Marcin; (...); Rosenkranz, Stephan

Article. 10.1002/ehf2.15203. 2025

  • Open Access.

Campos de estudio

Compartir